Synonyms:
Aerius;
Clarinex;
Clarinex;
KS-1048;
MCULE-2975958622;
NC00412;
NSC 675447;
NSC-675447;
NSC-759824;
SB17503;
Desloratadine, powder, >=98% (HPLC);
NCGC00159325-03;
NCGC00159325-04;
Descarboethoxyloratadine;
NCGC00159325-05;
AN-15105;
BC205533;
CC-26349;
SAM001246545;
SC-17296;
SBI-0206828.P001;
AB0012600;
LS-181814;
RT-012269;
Neoclarityn;
TL8000065;
D3787;
FT-0602522;
R3930;
ST24046429;
SW197792-3;
A19515;
D03693;
J10309;
AB00456701-11;
Sch-34117;
AB00456701-13;
AB00456701_14;
AB00456701_15;
643D718;
C-19255;
L001025;
I06-1866;
SR-01000668962-4;
SR-01000668962-5;
SR-01000668962-8;
Aerius;
BRD-K82357231-001-13-4;
Desloratadine, European Pharmacopoeia (EP) Reference Standard;
Desloratadine, United States Pharmacopeia (USP) Reference Standard;
4-(8-chloro-5,6-dihydro-11 H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine;
4-(8-chloro-5,6-dihydro-11H-benzo-[5,6]cyclohepta(1,2-b]pyridin-11-ylidene)-piperidine;
4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta [1,2-b]pyridin-11-ylidene) piperidine;
4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene) piperidine;
5H-Benzo(5,6)cyclohepta(1,2-b)pyridine,8-chloro-6,11-dihydro-11-(4-piperidinyllidene)-;
8-chloro-11-(4-piperidyliden)-6,11-dihydro-5H-benzo[5,6]cyclohepta [1,2-b]pyridine;
8-chloro-11-(4-piperidyliden)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine;
Azomyr;
8-chloro-11-(4-piperidylidene)-6,11-dihydro-5h-benzo[5.6]cyclohepta[1,2-b]pyridine;
8-chloro-6,11-dihydro-11-(4-piperdinylidene)-5h-benzo[5,6]cyclohepta[1,2-b]pyridine;
8-Chloro-6,11-dihydro-11-(4-piperidinylidene)-5H- benzo[5,6]cyclohepta[1,2,b]pyridine;
8-chloro-6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine;
Desloratadine for system suitability, European Pharmacopoeia (EP) Reference Standard;
Desloratidine, Pharmaceutical Secondary Standard; Certified Reference Material;
Loratadine Related Compound A, United States Pharmacopeia (USP) Reference Standard;
13-chloro-2-(piperidin-4-ylidene)-4-azatricyclo[9.4.0.0;{3,8}]pentadeca-1(11),3,5,7,12,14-hexaene;
8-CHLORO-11-(4-PIPERIDYLIDENE)-6,11-DIHYDRO-5H-BENZO[5,6]CYCLOHEPTA[1,2-b]PYRIDINE;
8-Chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine (Descarboethoxyloratadine; Desloratadine);
Desloratidine;
delopedil;
Claritin;
Claritin-D;
Claramax (TN);
NeoClarityn (TN);
Aerius (TN);
Desloratadine Actavis;
descarboethoxyloratidine;
D01GBY;
Desloratadine (USAN/INN);
Denosin;
Essex brand of desloratadine;
Deoxycholic acid, sodium salt;
descarboethoxyloratadine acetate;
Schering brand of desloratadine;
C19-H19-Cl-N2;
Desloratadine, 98% - 1G 1g;
CID124087;
Schering-Plough brand of desloratadine;
ACN-046380;
BCP9000599;
Sch 34117;
CS-O-00556;
B1571;
C121345;
5h-benzo[5,6]ciclohepta[1,2-b]piridina, 8-cloro-6,11-dihidro-11-(4-piperidinilideno)-;
DCL;
Descarboethoxyoratidine;
descarboethoxyloratadine;
Clarinex RediTabs;
8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine;
UNII-FVF865388R;
MFCD00871949;
CHEMBL1172;
MLS000559042;
CHEBI:291342;
JAUOIFJMECXRGI-UHFFFAOYSA-N;
FVF865388R;
8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine;
descarboethoxyloratadine acetate;
8-Chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine;
NCGC00159325-02;
AK163520;
CPD000149358;
SMR000149358;
Opulis;
Allex;
5H-Benzo[5,6]cyclohepta[1,2-b]pyridine, 8-chloro-6,11-dihydro-11-(4-piperidinylidene)-;
8-Chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine;
DSSTox_CID_24196;
desloratadine;
DSSTox_RID_80112;
DSSTox_GSID_44196;
C19H19ClN2;
Q-200936;
Desloratadine [USAN];
Claramax;
Desalex;
5H-Benzo(5,6)cyclohepta(1,2-b)pyridine, 8-chloro-6,11-dihydro-11-(4-piperidinylidene)-;
8-chloro-11-piperidin-4-ylidene-5,6-dihydrobenzo[1,2]cyclohepta[2,4-b]pyridine;
Clarinex (TN);
Neoclarityn;
CAS-100643-71-8;
SR-01000668962;
Desloratadine [USAN:INN:BAN];
Clarinex(R);
4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta(1,2-b]pyridin-11-ylidene)-piperidine;
4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine;
4-{8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene}-piperidine;
4-{8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene}piperidine;
MK-4117;
AC1L3XUD;
SCH 34117;
Opera_ID_1891;
SCHEMBL4425;
MLS000759406;
MLS001201801;
MLS001424247;
BEN691;
GTPL7157;
ZINC1261;
Desloratadine (JAN/USAN/INN);
DTXSID1044196;
SCH-34117;
CTK8B3353;
HMS2052H05;
HMS2090C06;
HMS2093F19;
HMS3394H05;
HMS3652O15;
HMS3715J15;
Pharmakon1600-01505393;
ALBB-027276;
BCP02340;
Desloratadine;
HY-B0539;
KS-00000G0C;
ZX-AN025785;
Tox21_111574;
ANW-42359;
BBL010777;
BDBM50073179;
BG0513;
CD0143;
NSC675447;
100643-71-8;
NSC759824;
s4012;
STK586537;
AKOS000280921;
Tox21_111574_1;
AC-1279;
API0002262;
CCG-101162;
CS-2639;
DB00967;
Keywords: 100643-71-8,MFCD00871949,1P00030X,5H-Benzo[5,6]cyclohepta[1,2-b]pyridine, 8-chloro-6,11-dihydro-11-(4-piperidinylidene)-,C19H19ClN2